Health Institutes of Türkiye (TUSEB)

The Results of TURKOVAC published in VACCINES

Last Added News

Agreement Has Been Signed Between TÜSEB and USHAŞ for the International Provision of Accreditation Services

The Memorandum of Understanding on Health Research Signed Between the Republic of Türkiye Ministry of Health, TÜSEB, and IHME.

Türkiye–Uk Bilateral Meeting On Strengthening General Immunization And Lifelong Vaccine Uptake Convened In Ankara

Tüseb And Social Security Institution (SGK) Launch Strategic Partnership Protocol Focused On Health Policy Development And Healthcare Financing

Under The Framework Of The Century Of Healthy Türkiye – Innovative Health Model, The Tüseb Technology Transfer Office Antalya City Hospital Branch Has Commenced Operations

Detailed Specifications For 2026 Tüseb Project Support Calls Have Been Published!

Inauguration Of Antalya City Hospital Branch Of The Health Institutes Of Türkiye (Tüseb) Technology Transfer Office

Training Program Conducted By Tüseb Technology Transfer Office (TTO) For The Personnel Of City Hospital Tto Branch Offices

Launch Of The 2026 International Joint Call For ‘Multi-Country Investigator-Initiated Clinical Trials In Cardiovascular, Autoimmune, And Metabolic Diseases’ Under The Era4health Partnership

PRELIMINARY INFORMATION ON THE 2026 CALL CALENDAR RELEASED

ALL NEWS

The results of pre-clinical trials of Inactivated COVID-19 Vaccine TURKOVAC developed in cooperation with Health Institutes of Turkey (TUSEB) and Erciyes University were published in one of the distinguished scientific journals “Vaccines”.

Please click here to see full text of “Development of an Inactivated Vaccine against SARS CoV-2”.

November 3, 2021